Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001564590-21-006189
Filing Date
2021-02-17
Accepted
2021-02-17 06:41:38
Documents
8
Period of Report
2021-02-17

Document Format Files

Seq Description Document Type Size
1 6-K bntx-6k_20210216.htm 6-K 17802
2 EX-99.1 bntx-ex991_40.htm EX-99.1 43671
3 GRAPHIC giwyawa45ad5000003.jpg GRAPHIC 780
4 GRAPHIC giwyawa45ad5000004.jpg GRAPHIC 780
5 GRAPHIC gu0fixzd3tdx000001.jpg GRAPHIC 14752
6 GRAPHIC gu0fixzd3tdx000002.jpg GRAPHIC 9298
7 GRAPHIC giwyawa45ad5000001.jpg GRAPHIC 780
8 GRAPHIC giwyawa45ad5000002.jpg GRAPHIC 780
  Complete submission text file 0001564590-21-006189.txt   100803
Mailing Address AN DER GOLDGRUBE 12 MAINZ 2M 55131
Business Address AN DER GOLDGRUBE 12 MAINZ 2M 55131 0049613190847081
BioNTech SE (Filer) CIK: 0001776985 (see all company filings)

EIN.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39081 | Film No.: 21642596
SIC: 2836 Biological Products, (No Diagnostic Substances)